Výsledky vyhľadávania - "Multiple Sclerosis epidemiology"

  1. 1
  2. 2

    Zdroj: J Neurol
    Dipòsit Digital de Documents de la UAB
    Universitat Autònoma de Barcelona
    Journal of Neurology
    r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
    Institut de Recerca Germans Trias i Pujol (IGTP)
    Journal of neurology, Vol. 271, no.9, p. 5813-5824 (2024)
    JOURNAL OF NEUROLOGY

    Popis súboru: application/pdf

  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13

    Autori: Li, Ying Saul, Alice Taylor, Bruce a ďalší

    Prispievatelia: Li, Ying Saul, Alice Taylor, Bruce a ďalší

    Zdroj: J Neurol
    Journal of Neurology
    r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
    Institut de Recerca Germans Trias i Pujol (IGTP)
    Repositorio Institucional de la Consejería de Sanidad de la Comunidad de Madrid
    Consejería de Sanidad de la Comunidad de Madrid
    JOURNAL OF NEUROLOGY
    r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
    Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)
    Journal of neurology, Vol. 271, no.1, p. 472-485 (2024)
    Journal of Neurology, Vol. 271, no.1, p. 472-485 (2023)
    Journal of neurology

    Popis súboru: application/pdf; application/msword; application/vnd.openxmlformats-officedocument.spreadsheetml.sheet

  14. 14

    Zdroj: Front Immunol
    Frontiers in Immunology, Vol 15 (2024)
    Samadzadeh, S, Adnan, R, Berglova, P, Barzegar, M, Debrabant, B, Roikjaer, S G, Levy, M, Petzold, A, Palace, J, Flanagan, E P, Mariotto, S, Skou, S T, Froelich, A, Lotan, I, Messina, S, Geraldes, R, Asseyer, S, Stiebel-Kalish, H, Oertel, F C, Shaygannejad, V, Sahraian, M A, Kim, H J, Bennett, J L, Böttcher, C, Zimmermann, H G, Weinshenker, B G, Paul, F & Asgari, N 2024, 'Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT)', Frontiers in Immunology, vol. 15, 1380025. https://doi.org/10.3389/fimmu.2024.1380025
    Samadzadeh, S, Adnan, R, Berglova, P, Barzegar, M, Debrabant, B, Roikjaer, S G, Levy, M, Petzold, A, Palace, J, Flanagan, E P, Mariotto, S, Skou, S T, Froelich, A, Lotan, I, Messina, S, Geraldes, R, Asseyer, S, Stiebel-Kalish, H, Oertel, F C, Shaygannejad, V, Sahraian, M A, Kim, H J, Bennett, J L, Böttcher, C, Zimmermann, H G, Weinshenker, B G, Paul, F & Asgari, N 2024, ' Protocol of a prospective multicenter study on comorbidity impact on multiple sclerosis and antibody-mediated diseases of the central nervous system (COMMIT) ', Frontiers in Immunology, vol. 15, 1380025 . https://doi.org/10.3389/fimmu.2024.1380025

    Popis súboru: application/pdf

  15. 15

    Zdroj: BMC Neurol
    BMC Neurology, Vol 24, Iss 1, Pp 1-10 (2024)
    BMC neurology, 24(1):123

    Popis súboru: application/pdf; pdf

  16. 16
  17. 17
  18. 18
  19. 19

    Prispievatelia: Maria Pia Sormani Marco Salvetti Pierre Labauge a ďalší

    Zdroj: Ann Clin Transl Neurol
    Annals of Clinical and Translational Neurology, Vol 8, Iss 8, Pp 1738-1744 (2021)
    Annals of clinical and translational neurology, vol. 8, no. 8, pp. 1738-1744

    Predmety: Adult, Male, 0301 basic medicine, adult, antibodies, monoclonal, humanized, covid-19, female, france, humans, immunologic factors, interferons, italy, male, meta-analysis as topic, middle aged, multiple sclerosis, multivariate analysis, protective factors, retrospective studies, risk factors, rituximab, severity of illness index, Multiple Sclerosis, Neurosciences. Biological psychiatry. Neuropsychiatry, Antibodies, Monoclonal, Humanized/adverse effects, Antibodies, Monoclonal, Humanized/pharmacology, COVID-19/epidemiology, COVID-19/physiopathology, Female, France/epidemiology, Humans, Immunologic Factors/adverse effects, Immunologic Factors/pharmacology, Interferons/adverse effects, Interferons/pharmacology, Italy/epidemiology, Meta-Analysis as Topic, Middle Aged, Multiple Sclerosis/drug therapy, Multiple Sclerosis/epidemiology, Multivariate Analysis, Protective Factors, Retrospective Studies, Risk Factors, Rituximab/adverse effects, Rituximab/pharmacology, Severity of Illness Index, Antibodies, Monoclonal, Humanized, Antibodies, COVID-19, France, Immunologic Factors, Interferons, Italy, Rituximab, 03 medical and health sciences, Immunologic Factor, 0302 clinical medicine, Retrospective Studie, Monoclonal, Multiple Sclerosi, [SDV.NEU] Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC], RC346-429, Humanized, Multivariate Analysi, Protective Factor, Risk Factor, 3. Good health, [SDV] Life Sciences [q-bio], Settore MED/26 - NEUROLOGIA, Interferon, Neurology. Diseases of the nervous system, Brief Communications, Human, RC321-571

    Popis súboru: application/pdf; STAMPA

  20. 20

    Prispievatelia: Amato M. P. Fonderico M. Portaccio E. a ďalší

    Zdroj: Brain. 143:3013-3024

    Popis súboru: application/pdf